Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Ignite Study: Naltrexone/Bupropion for Weight Loss
NCT01764386Phase 3Completed
- Sponsor
- Orexigen Therapeutics
- Start
- Feb 2013
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of naltrexone + bupropion in obesity, Overweight, sponsored by Orexigen Therapeutics. Started Feb 2013; status: completed.
02
Drugs
naltrexone + bupropion
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT01764386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01764386.